Survival outcome in childhood ALL: Experience from a tertiary care centre in North India

Pediatric Blood and Cancer

Volumn 53, Issue 2, 2009, Pages 168-173

  Kulkarni, K P ^a   Marwaha, R K ^a   Trehan, A ^a   Bansal, D ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Event free survival; Overall survival; Prognostic factors; Relapse

Indexed keywords

ASPARAGINASE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; HYDROCORTISONE; MERCAPTOPURINE; METHOTREXATE; PREDNISOLONE; TIOGUANINE; VINCRISTINE; ANTINEOPLASTIC AGENT;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER RELAPSE; CANCER RISK; CANCER SURVIVAL; CARCINOGENESIS; CAUSE OF DEATH; CHILD; CHILDHOOD LEUKEMIA; DEMOGRAPHY; DISEASE COURSE; DRUG PULSE THERAPY; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HOSPITALIZED CHILD; HUMAN; LYMPHADENOPATHY; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; RADIATION DOSE; REPEATED DRUG DOSE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCHOOL CHILD; SKULL IRRADIATION; SURVIVAL RATE; TERTIARY HEALTH CARE; THROMBOCYTE COUNT; TREATMENT DURATION; TREATMENT OUTCOME; ADOLESCENT; INDIA; KAPLAN MEIER METHOD; MORTALITY; PATHOPHYSIOLOGY; PROGNOSIS;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INDIA; KAPLAN-MEIERS ESTIMATE; MALE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 67649996027     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21897     Document Type: Article

References (42)

1. Pui CH, Evans WE. Acute lymphoblastic leukemia. N Engl J Med 1998;339:605-615.
2. Gaynon PS. Childhood acute lymphoblastic leukemia and relapse. Br J Haematol 2005;131:579-587. (Pubitemid 43903802)
3. Chessells JM, Hardisty RM, Richards S. Long survival in childhood lymphoblastic leukaemia. Br J Cancer 1987;55:315-319. (Pubitemid 17036848)
4. Chessells JM. Recent advances in the management of acute leukemia. Arch Dis Child 2000;82:438-442. (Pubitemid 30367050)
5. Bleyer WA. Acute lymphoblastic leukemia in children: Advances and prospectus. Cancer 1990;65:689-695. (Pubitemid 20067249)
6. Pui CH, Sandlund JT, Pei D. Results of therapy for acute lymphoblastic leukemia in black and white children. JAMA 2003;290:2001-2007. (Pubitemid 37430582)
7. Pui CH, Evans WE. Treatment of acute lymphoblastic leukemia. N Engl J Med 2006;354:166-178.
8. Pullen J, Shuster JJ, Link M. Significance of commonly used prognostic factors differs for children with T cell acute lymphocytic leukemia (ALL), as compared to those with B-precursor ALL. Leukemia 1999;13:1696-1707. (Pubitemid 29535250)
9. Simone JV. Factors that influence haematological remission duration in acute lymphocytic leukemia. Br J Haematol 1976;32: 465-472.
10. Pui CH, Schrappe M, Ribeiro MC, et al. Childhood and adolescent lymphoid and myeloid leukemia. Hematology 2004;1:118-145.
11. Rubnitz JE, Pui CH. Childhood acute lymphoblastic leukemia. Oncologist 1997;2:374-380.
12. Aur RJ, Simone JV, Verzosa MS, et al. Childhood acute lymphocytic leukemia: Study VIII. Cancer 1978;42:2123-2134. (Pubitemid 9125865)
13. Crist W, Boyett J, Pullen J, et al. Clinical and biologic features predict poor prognosis in acute lymphoid leukemias in children and adolescents: A Pediatric Oncology Group review. Med Pediatr Oncol 1986;14:135-139. (Pubitemid 16054577)
14. Shanta V, Maitreyan V, Sagar TG, et al. Prognostic variables and survival in pediatric acute lymphoblastic leukemias: Cancer Institute experience. Pediatr Hematol Oncol 1996;13:205-216. (Pubitemid 26146272)
15. Vaidya SJ, Advani SH, Pai SK, et al. Survival of childhood acute lymphoblastic leukemia: Results of therapy at Tata Memorial Hospital, Bombay, India. Leuk Lymphoma 1996;20:311-315.
16. Magrath I, Shanta V, Advani S, et al. Treatment of acute lymphoblastic leukaemia in countries with limited resources; lessons from use of a single protocol in India over a twenty year period. Eur J Cancer 2005;41:1570-1583. (Pubitemid 40981839)
17. Cohen LF, Balow JE, Magrath IT. Acute tumor lysis syndrome: A review of 37 patients with Burkitt's lymphoma. Am J Med 1980;68:486-491. (Pubitemid 10141811)
18. Barrington SF, Carr R. Staging of Burkitt's lymphoma and response to treatment monitored by PET scanning. J Clin Oncol 1995;7: 334-335.
19. Magrath IT, Janus C, Edwards BK. An effective therapy for both undifferentiated (including Burkitt's) lymphomas and lymphoblastic lymphomas in children and young adults. Blood 1984;63: 1102-1111. (Pubitemid 14100910)
20. Ziegler JL. Chemotherapy of Burkitt's lymphoma. Cancer 1972; 30:1534-1540.
21. Ziegler JL, Bluming AZ, Fass L, et al. Relapse patterns in Burkitt's lymphoma. Cancer Res 1972;32:1267-1272.
22. Mishra D, Singh HP. Kuppuswami's socioeconomic scale status - A revision. Indian J Pediatr 2003;70:273-274. (Pubitemid 36560159)
23. Advani SH, Rao DN, Gopal R, et al. Acute lymphoblastic leukemia: End-result analysis of treatment and prognostic factors in Indian patients. Am J Hematol 1983;15:35-43.
24. Advani SH, Iyer RS, Pai SK, et al., Four-agent induction/consolidation therapy for childhood acute lymphoblastic leukemia: An Indian experience. Am J Hematol 1992;39:242-248.
25. Advani S, PAi S, Venzon D, et al. Acute lymphoblastic leukaemia in India: An analysis of prognostic factors using a single treatment regimen. Ann Oncol 1999;10:167-176. (Pubitemid 29113176)
26. Silverman LB, Gelber RD, Dalton VK, et al. Improved outcome for children with acute lymphoblastic leukemia: Results of Dana-Farber Consortium Protocol 91-0. Blood 2001;97:1211-1218. (Pubitemid 32183741)
27. Chessells JM, Bailey C, Richards SM. Intensification of treatment and survival in children with lymphoblastic leukaemia: Results of UK Medical Research Council trial UKALL X. Medical Research Council Working Party on Childhood Leukaemia. Lancet 1995; 345:143-148.
28. Wessels G, Hassling PB, Buurman M, et al. An analysis of prognostic variables in acute lymphocytic leukaemia in a heterogeneous South African population. J Trop Pediatr 1997;43:156-161. (Pubitemid 27313685)
29. Kadan-Lottick NS, Ness KK, Bhatia S, et al. Survival variability by race and ethnicity in childhood ALL. JAMA2003;290:2014-2018.
30. Higgins CD, dos-Santos-Silva I, Stiller CA, et al. Season of birth and diagnosis of children with leukaemia. Br J Cancer 2001;84: 406-412.
31. Douglas S, Cortina-Borja M, Cartwright R. A quest for seasonality in presentation of leukaemia and non-Hodgkins lymphoma. Leuk Lymphoma 1999;32:523-532. (Pubitemid 29086367)
32. Hussein H, Sidhom I, Naga SA, et al. Outcome and prognostic factors of acute lymphoblastic leukemia in children at the National Cancer Institute, Egypt. J Pediatr Hematol Oncol 2004;26:507-514. (Pubitemid 39045468)
33. Kumar R, Marwaha RK, Bhalla AK, et al. Protein energy malnutrition and skeletal muscle wasting in childhood acute lymphoblastic leukaemia. Ind Pediatr 2000;37:720-726. (Pubitemid 30483164)
34. Hiyoshi Y, Fujimoto T, Kuriya N, et al. Therapy outcome in childhood ALL. Jpn J Clin Oncol 1985;15:13-23.
35. Horibe K, Hara J, Yagi K, et al. Prognostic factors in childhood acute lymphoblastic leukemia in Japan. Int J Hematol 2000;72:61-68.
36. Li CK, Chik KW, Chan GCF, et al. Treatment of acute lymphoblastic leukemia in Hong Kong children: HKALL 93 study. Hematol Oncol 2003;21:1-9.
37. Miller RD, Leikin S, Albo V, et al., Prognostic factors and therapy in acute lymphoblastic leukemia of childhood: CCG-141: A report from childrens cancer study group. Cancer 1983;51:1041-1049. (Pubitemid 13158794)
38. Shing MK, Li CK, Chik KW, et al. Outcomes and prognostic factors of Chinese children with acute lymphoblastic leukemia in Hong Kong: Preliminary results. Med Pediatr Oncol 1999;32:117-123.
39. Smith M, Arthur D, Camitta B, et al. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol 1996;14:18-24. (Pubitemid 26019992)
40. Shrappe M. Prognostic factors in childhood acute lymphoblastic leukaemia. Indian J Pediatr 2003;70:817-824. (Pubitemid 37420388)
41. Bhatia S, Sather H, Heerema NA. Racial and ethnic differences in survival of children with acute lymphoblastic leukaemia. Blood 2002;100:1957-1964. (Pubitemid 35001223)
42. Maloney KW, Schuster JJ, Murphy S. long term results of treatment studies for childhood acute lymphoblastic leukaemia: Pediatric Oncology Group studies from 1986 to 1994. Leukaemia 2000; 14:2276-2285.